Skip to content
Open access

Multi-Omics Mendelian Randomization Identifies DDX17 as a Potential Mediator Linking Gut Microbiota-Immune-Metabolism Axis to Alzheimer’s Disease

Nov 2026 · International Journal of General Medicine · Vol 19 · 0 citations · 30 references
Medicine

Abstract

Introduction The gut microbiota-immune-metabolism axis has been implicated in Alzheimer’s disease (AD) pathogenesis; however, the key host molecular targets linking peripheral dysregulation to central neurodegeneration remain elusive. Methods In this study, we systematically integrated large-scale GWAS data covering 1,903 gut microbiota taxa, 14,696 immune cell features, and 34,843 metabolite features with AD GWAS summary statistics, using two-sample Mendelian randomization (MR) to identify causal genes. These genes were intersected with differentially expressed genes from three GEO datasets, followed by protein-protein interaction network construction using four Cytoscape algorithms (MCC, EPC, DMNC, Degree) and feature selection via three machine learning methods (Support Vector Machine, Random Forest, LASSO). Single-cell transcriptomics (GSE188545) localized key gene expression, Support Vector Machine virtual knockout (scTenifoldKnk) analyzed downstream regulatory networks, with in vitro validation performed in okadaic acid-treated SH-SY5Y cells using RT-qPCR and Western blotting. Results MR analysis revealed multiple causal associations among microbial taxa, immune phenotypes, metabolites, and AD. Integration of MR causal genes with DEGs, PPI network analysis, and machine learning refinement prioritized six key genes: BYSL, DDX17, HSPA6, RRN3, C4B, and NCKAP1L. Among them, only DDX17 showed robust expression in AD-associated neuronal populations in single-cell transcriptomics, whereas the other five genes showed low expression and may act through non-cell-autonomous mechanisms. Virtual knockout predicted that the PI3K/AKT pathway was the most significantly enriched downstream of DDX17 perturbation. In vitro, DDX17 was significantly upregulated in an OA-induced AD cell model, and siRNA-mediated knockdown partially reversed tau hyperphosphorylation (total P-tau and P-tau Thr217), while restoring AKT phosphorylation at Thr308 and Ser473. Conclusion These findings suggest that DDX17 is a potential downstream host candidate linking peripheral dysregulation to tau pathology in AD, partially through PI3K/AKT pathway modulation. However, these results are primarily hypothesis-generating, and direct mechanistic and in vivo validation remain essential.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.